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Abstract 
 
Viruses are spherical or complex shaped carriers of 
proteins, nucleic acids and sometimes lipids and 
sugars. They are metastable and poised for structural 
changes. These features allow viruses to communicate 
with host cells during entry, and to release the viral 
genome, a process known as uncoating. Studies have 
shown that hundreds of host factors directly or indirectly 
support this process. The cell provides molecules that 
promote stepwise virus uncoating, and direct the virus 
to the site of replication. It acts akin to a snooker player 
who delivers accurate and timely shots (cues) to the 
ball (virus) to score. The viruses, on the other hand, 
trick (snooker) the host, hijack its homeostasis systems, 
and dampen innate immune responses directed against 
danger signals. In this review, we discuss how cellular 
cues, facilitators, and built-in viral mechanisms promote 
uncoating. Cues come from receptors, enzymes, and 
chemicals that act directly on the virus particle to alter 
its structure, trafficking and infectivity. Facilitators are 
defined as host proteins that are involved in processes 
which indirectly enhance entry or uncoating. Unraveling 
the mechanisms of virus uncoating will continue to 
enhance understanding of cell functions, and help 
counteracting infections with chemicals and vaccines. 
 
How cellular cues and facilitators shape the viral 
uncoating program 
 
Virus entry is the process by which the genome of a 
virus particle is delivered to the replication site, which 
can be in the cytosol, on cytoplasmic membranes or in 
the nucleus. The viral uncoating program is encoded in 
the viral genome together with the blueprint for the 
production of progeny viruses. The majority of viruses 
link their uncoating program to the endocytic machinery 
(for summary, see Figure 1) (1). The details of 
uncoating are highly variable depending on the nature 
of the virus and the cell. However, the profile of events 
is similar for most viruses. It involves a stepwise 
process with a final step, the release of the genome 
from a protective, confining capsid structure (2, 3). The 
final step enables transcription and replication, or in the 
case of DNA and RNA retroviruses the stable 
maintenance of the viral genome in the host nucleus. 
As a rule, complete uncoating occurs once the capsid 
has reached its final destination (4). The steps of 
uncoating are regulated by cellular cues, which directly 
act on the virus. Here we have categorized cellular 
factors exerting cues to promote entry and uncoating of 
the incoming particle. The three major cues come from 
host receptors, enzymes and small chemicals including 
ions.   
 
Receptor cues come from plasma membrane 
associated molecules (proteins, sugars, lipids). They 
bind the virus to a cell, and actively promote virus 
endocytosis. They mediate conformational changes in 
the virion (a virus particle outside the cell) or the virus, 
and promote the formation of microdomains that trigger 
signaling pathways and enable the infection process (1, 
4-7). Signaling plays a critical role in virus entry. 
Receptors often follow the virus into the cell during 
endocytosis, as shown with dendritic cell-specific 
intercellular adhesion molecule 3-grabbing nonintegrin 
(DC-SIGN) and bunyavirus (8). Intracellular receptors 
found in the endocytic pathway can also play an 
important role in viral fusion and escape into the 
cytosol. Examples are Niemann-Pick C1 (NPC1) for 
Ebola virus and lysosome associated membrane 
protein 1 (LAMP1) for Lassa virus (9, 10). A receptor 
cue and actomyosin work together in virion surfing at 
the extracellular part of the plasma membrane (11-15). 
Enzymatic cues include oxido-reduction, quality control 
machineries such as the ubiquitin proteasome system 
(UPS), endoplasmic reticulum (ER)-associated protein 
degradation (ERAD) and disaggregation. A good 
example is simian virus 40 (SV40), a polyomavirus 
whose uncoating process in the ER has been studied in 
detail (16-23) (see also chapter ‘Uncoating cues and 
facilitators’). Further to this, protease digestion can 
activate viral spike proteins that facilitate virus fusion 
with host membranes and escape of many viruses from 
endosomes (24). Enzymatic activity can also result in 
generation of mechanical/physical forces involving 
cytoskeletal motors (dynein, kinesin, myosin), the 
cytoskeleton (tubulin, actin filaments), and the nuclear 
pore complex (NPC). Such forces can alter the physical 
properties of the capsid and promote uncoating and 
genome release (11, 25, 26).  
Chemical cues such as low pH, and changes in other 
ion concentrations are, for example, spatiotemporally 
regulated during endosome maturation (27, 28). They 
trigger conformational changes in the viral envelope, 
the coat or the nucleic acid-protein core of incoming 
viruses (29, 30). Changes in chemical properties 
between different cellular compartments, such as from 
ER to cytosol (16), or endosome to cytosol, can 
promote further steps of uncoating.  
Facilitators are host factors (proteins, sugars, lipids, 
ions) that enhance viral uncoating, but do so in an 
indirect manner compared to the cues.  According to 
current knowledge, facilitators do not directly bind to the 
virus. Examples include cell signaling molecules, such 
as Ca2+ transients in the cytosol, endosome maturation 
factors, or intracellular transport factors, such as actin 
and microtubule filaments. 
A summary of cellular cues and processes implicated in 
virus uncoating is shown in Figure 2. 
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Viral strategies that promote uncoating  
Viruses have built-in mechanisms that respond to 
cellular cues and facilitators, in order to promote entry 
and uncoating. For example, by containing 
phosphatidylserine (PS) within their membranes viruses 
can effectively mimic apoptotic cells, thereby subverting 
apoptotic clearance mechanisms to facilitate entry or 
infection (31). Below we list some of the strategies used 
by viruses. 
a) Low pH-activated viral fusion. Virus-cell fusion is 
the means by which all enveloped viruses, including 
HIV, influenza and Ebola virus enter cells. It requires 
bringing two separate membrane bilayers into intimate 
contact and then merging them into one. It is executed 
by one or more viral surface glycoproteins. The sole 
cue so far known to trigger fusion of orthomyxo-, 
rhabdo-, alpha-, flavi-, bunya-, and arenaviruses is low 
pH (32). A recently discovered family of cellular factors 
with anti-viral activity are interferon inducible 
transmembrane (IFITM) proteins. They have the ability 
to inhibit viral entry, possibly by modulating the fluidity 
of cellular membranes and blocking fusion (33).  
b) Low pH-activated viral protease and glycosidase. 
Some viruses activate proteolytic activity in response to 
an acidic environment. Adeno-associated virus (AAV) is 
capable of autolytic cleavage at multiple sites within the 
capsid, which is induced at pH 5.5 (34). This cleavage 
may contribute to the escape of AAV from acidic 
endosomes during entry. The (NA) of H5N1 influenza A 
virus was shown to have high catalytic activity at low 
pH, and to cleave glycosylated LAMPs. The main 
activity of NA is to release newly assembled virus 
particles from the cell surface (35). NA inhibitors can 
also reduce early stages of infection, and it is possible 
that NA activity in late endosomes is required for 
optimal virus entry (36).  
 
c) Capsid softening and internal pressure. Using 
atomic force microscopy (AFM) at virion resolution, it 
was found that influenza virus particles soften following 
acidification of the viral core. This is due to acid-induced 
conformational changes of the capsid independent of 
the viral glycoproteins (37-39). Assembled adenovirus 
particles contain an estimated internal pressure of 30 
atmospheres, which is thought to assist in the stepwise 
virus disassembly process, starting at the physically 
weakest spot of the virus, the five-fold symmetrical 
vertex (2, 11, 40-44). Chemical and mechanical stability 
have been known to correlate in bacteriophage T7 (45), 
and internal pressure with capsid stiffness in phage 
phi29 (46). The resistance of the adenovirus vertex 
depends on virus maturation, which is mediated by the 
adenovirus cysteine protease AVP (47, 48), and also on 
innate factors against the virus, such as defensins 
which bind to and stabilize the vertex region (49). 
Pressure within the virus particle is built up by 
electrostatic repulsion between the negatively charged 
dsDNA strands, DNA bending and entropic 
components, and is thought to weaken the pentons 
(50). It eventually facilitates genome ejection for DNA 
translocation into the nucleus, a strategy acquired by 
bacteriophage and certain eukaryotic viruses such as 
herpesviruses (46, 51).  
d) Directional genome uncoating. Human 
rhinoviruses (HRVs) are the major cause of the 
common cold. The uncoating process of the minor 
group virus HRV2 begins with low density lipoprotein 
receptor (LDLR) binding, and clathrin-dependent and -
independent endocytosis (52, 53). Conversion of the 
capsid to subviral particles is induced by low pH in late 
endosomes, and VP1 and VP4 insert into the 
endosomal lumen creating an ion-conducting pore (30, 
54, 55). The 3’-end of the linear RNA genome exits 
from the capsid first, suggesting that the RNA adopts a 
defined conformation inside the viral capsid (56).  
e) The assembly-disassembly paradox. How can a 
virus be assembled in an infected cell and fall apart 
(disassemble) during entry into an uninfected cell? One 
possibility is that virus capsid is assembled as a stable 
structure in an infected cell and rendered metastable, 
for example by limited proteolysis, such that it can 
receive cues from the host (3). A well studied example 
here is adenovirus (48). A second possibility is that the 
virus particle itself is unchanged during assembly and 
egress, but that the infected and uninfected cells are 
different. An uncoating factor may be absent (inactive) 
during assembly, but present (active) during viral entry. 
Semliki Forest virus (SFV) (see Box 1) and influenza 
virus uses this strategy (25, 57, 58). During assembly of 
influenza virus, proton flux through the viral M2 ion 
channel, which is present in the Golgi membrane, 
neutralizes the acidic pH of the trans-Golgi network 
(TGN) and thereby prevents activation of the newly 
synthesized hemagglutinin (HA) to its fusogenic form 
(59-62). A third possibility is that the virus is unchanged 
but assembly and uncoating are spatially separated (3, 
63). Polyomaviruses, for example, are uncoated in the 
ER, but assembled inside the nucleus (18, 64). 
Influenza viral ribonucleoprotein (vRNPs) are prevented 
from re-import after replication, or following 
microinjection into infected cells due to vRNP binding to 
newly expressed viral matrix protein (M1) (65, 66). 
Replicated adenovirus DNA cannot undergo inter-
nuclear spreading upon fusion of an infected cell with 
uninfected neighboring cells (67). To be infectious, 
progeny viruses must be released and go through an 
uncoating program during entry into a new cell.   
 
As we described above, viruses have evolved to 
navigate the networks of host genes, proteins, lipids 
and RNAs, as well as metabolic and catabolic 
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pathways. This allows viruses to couple their stepwise 
disassembly with the entry process into cells, leading 
them through chemically distinct cellular environments.  
 
Uncoating at the nuclear pore  
 
Many viruses replicate in the cytoplasm. Others travel 
into the nucleus for replication (68). For such viruses 
nuclear entry is a limiting step in infection. The 
vertebrate nuclear pore complex (NPC) has an 
estimated molecular mass of 125 MDa and is 
composed of 80-100 different proteins called 
nucleoporins (Nups) (69-71). The NPC has barrier and 
transport functions, with kinetic cargo size restriction of 
about 39 nm for receptor-mediated transport and 
solutes of about 40 kDa (71, 72). Cargo docking sites 
surround the pore on the cytoplasmic side, and the 
NPC structure constricts to form a dynamic basket on 
the nuclear side (73). The NPC is a major bottleneck for 
viruses to overcome during cell entry because it 
provides the only continuous aqueous connection 
between the cytoplasm and the nucleus (74). Nuclear 
entry and uncoating are often concomitant.  
 
a) NPC docking and genome release. Large virus 
capsids, such as those of herpesvirus (125 nm in 
diameter) and adenovirus (70-90 nm), are too large to 
enter the nucleus through the NPC. Instead, they follow 
a pathway of stepwise uncoating and weakening of the 
capsid to release their linear, double stranded (ds) DNA 
into the nucleus.  
Herpes simplex virus-1 (HSV-1) fuses at the plasma 
membrane, although endosomal fusion has also been 
reported (75). Capsids shed some outer tegument 
proteins into the cytosol. Some of these proteins, such 
as the major tegument protein VP16 (a potent 
transcription factor) are imported into the nucleus to 
enhance viral immediate early gene expression (76-78). 
The capsids and tightly bound inner tegument proteins 
bind to dynein and kinesin motors that regulate 
retrograde transport on microtubules toward the 
nucleus (76, 79-81). After docking to the NPC via 
Nup358 or Nup214, a single vertex of the capsid is 
opened, and viral DNA is released into the nucleus 
possibly by high internal capsid pressure (82-87). This 
model is analogous to DNA ejection by bacteriophages 
into bacterial cells (88).  
 
Adenovirus capsids, following endocytosis and 
endosomal escape, are transported along microtubules 
towards the nucleus, where they dock at the NPC via 
Nup214 and are disassembled by the outward pulling 
force generated by kinesin-1 and microtubules (26, 89-
91). After the capsid is disassembled, the viral genome 
translocates into the nucleus using nuclear import 
receptors and histone H1 (90-96). However, some viral 
DNA fail to be properly delivered into or retained within 
the nucleus (95, 97). This DNA misdelivery may give 
rise to inflammatory host responses which is a 
widespread feature of human adenovirus infections 
(98). 
b) Small viruses. Viruses with capsids smaller than 
about 40-50 nm, such as hepatitis B virus (HBV), 
parvoviruses and some polyomaviruses, can enter 
through the pores in either an intact form or as a 
subviral particle. HBV enters the nucleus to generate a 
covalently closed circular viral DNA genome (cccDNA) 
and to transcribe this genome. During the import 
process, immature capsids are initially trapped within 
the NPC via Nup153, and then undergo a maturation 
process and disassembly, which releases viral DNA 
and attached viral DNA polymerase to the nucleus by 
an nuclear localization signal (NLS)-dependent process 
(99, 100). Nuclear cccDNA is maintained in infected 
hepatocytes, and used for reduplication and assembly 
of progeny virus. The high persistence of cccDNA 
makes pharmacological treatment of chronically HBV 
infected individuals difficult (101, 102). Parvoviruses are 
thought to enter the nucleus as intact particles, or by 
transiently disrupting nuclear membranes, followed by 
disassembly in the nucleus, albeit mechanisms are 
unknown (103, 104). 
c) Rod-shaped genomes. Several negative-stranded 
RNA viruses such as influenza, Thogoto, and Borna 
disease viruses replicate their RNAs in the nucleus 
(105). Influenza circumvents the size limit of the NPC 
by encoding its genetic information on eight separate, 
rod-like vRNPs that are thin enough in diameter to enter 
through the pore. They resemble a twisted rod (10-
15nm in width and 30-120nm in length) that is folded 
back and coiled on itself (106, 107). Studies using 
amantadine have shown that acidification of the viral 
core in endosomes via the viral M2 channel is essential 
for the dissociation of incoming nucleocapsids in the 
cytosol following fusion (108, 109). After capsid 
uncoating, the vRNPs are released into the cytosol. 
Nucleoprotein (NP), the main component of vRNPs, 
contains NLSs necessary for nuclear import (110-115). 
Progeny vRNPs are exported to the cytosol after 
binding to M1 and nuclear export protein (NEP), and 
are prevented from re-import into the nucleus (116-
119). 
d) Uncoating factors and immune evasion. Human 
immunodeficiency virus type 1 (HIV-1) uncoating is 
controlled by host factors. Following fusion at the 
plasma membrane, cyclophilin A or TRIM5α destabilize 
the capsid. Transportin 3 (TNPO3), Nup358, cleavage 
and polyadenylation specificity factor subunit 6 
(CPSF6), dynein, kinesin-1 and components of the NPC 
regulate nuclear transport of the capsid and import of 
reverse transcribed DNA (120-128). In primary human 
macrophages, it was shown that recruitment of 
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cyclophilin A or CPSF6 to capsid protein (CA) prevents 
premature DNA synthesis, innate recognition, and 
interferon (IFN)-dependent restriction of HIV-1 (129). In 
addition, cytoplasmic pools of Nups may control 
uncoating by binding to the capsid, or mediate capsid or 
core docking to the NPC (130). TNPO3, a member of 
the importin β family, might play a role in displacing CA 
and tRNA from the preintegration complex in the 
nucleus, and thereby facilitate integration of the viral 
genome into host chromatin (127, 131).  
 
e) Actin nucleation mediates nuclear targeting. 
During entry viruses use microtubule-based 
mechanisms to traffic through the cytoplasm to the 
nucleus for replication (68). Baculoviruses are an 
exception, and after fusion at the plasma membrane the 
nucleocapsids move on actin tails through the 
cytoplasm in random directions (132). When they 
collide with the nucleus, they may be proximal to an 
NPC and dock to it for a few minutes. Thereafter the 
nucleocapsid (diameter 30-60nm) is thought to squeeze 
through the pore, as suggested by electron micrographs 
(133), followed by uncoating in the nucleus. Actin 
nucleation of baculovirus is mediated by Arp2/3 (134) 
and depolymerization of actin inhibits viral entry and 
infection kinetics (132). 
f) Mitosis for nuclear access. Unlike influenza virus, 
HIV-1, herpes-, and adenoviruses, HPV entry into the 
nucleus apparently does not require functional NPC. 
HPV16 is the causative agent of cervical cancer (135). 
It has evolved a strategy contingent with cell tropism in 
mucosal epithelia, and the skin, involving basal 
keratinocytes, which can be infected upon wounding.  It 
establishes persistent infection. After endocytosis, the 
virus travels from the endosome to the TGN and ER in 
a retromer- and γ-secretase dependent manner (136, 
137). Furthermore, access of the subviral DNA/L2 
complex to the nucleus depends on mitotic breakdown 
of the nuclear membrane (138, 139), or direct transfer 
from the ER into the nucleus during reassembly of the 
nuclear envelope (137). This correlates with the notion 
that papillomavirus exclusively infects basal stem cells 
that undergo cell division (140). Gamma-retroviruses 
must also wait for nuclear membrane breakdown during 
mitosis for nuclear delivery of preintegration complexes 
(141-143). 
(Box1) Break shot – technologies that advance 
virus entry studies  
 
Light microscopy, electron microscopy, and correlative 
microscopy. The imaging field has seen enormous 
progress in recent years, including wide field 
microscopy and total internal reflection microscopy 
(TIRF), atomic force microscopy (AFM), automated 
high-throughput imaging, lattice light-sheet microscopy, 
and super resolution microscopy (25, 95, 144, 145). 
Advance and dissemination of technology has 
revolutionized the field of virus entry. Imaging-based 
entry assays have been developed to quantify distinct 
step of virus entry (146, 147). Ethynyl-nucleotide 
labeling using EdA/U/C and CLICK chemistry enables 
temporal and spatial mapping of the virus genome of 
adeno, vaccinia, papilloma, and herpes virus (95, 148). 
The same technique was used to detect cellular DNA 
synthesis upregulation by paracrine signaling from a 
herpesvirus-infected cell to a remote, uninfected cell 
(149). Fluorescence in situ hybridization (FISH) has 
been used to detect incoming viral genomes and viral 
genome uncoating for coronavirus, adenovirus, 
rhinovirus or influenza virus (91, 150, 151). It is of note, 
however, that FISH is inherently non-quantitative, as 
the procedure tends to underestimate the amount of 
cytoplasmic viral genomes due to extraction in the 
denaturation process (91). This clearly favors 
bioorthogonal click-chemistry based approaches that 
have single molecule sensitivity (95, 152). Wide field 
fluorescence microscopy is increasingly used for 
automated analysis and quantification of virus 
spreading phenotypes in cell cultures (153, 154). For 
example, Plaque2.0 is a high-throughput software 
method yielding multi-parametric datasets of virus 
spreading in 2-D monolayers. It is compatible with 
immuno-cytochemistry and FISH. Proximity-dependent 
DNA ligation assay (PLA) has been used to detect 
incoming papillomavirus to the TGN and ER (136, 137, 
155). Fluorescence correlation spectroscopy (FCS) was 
used to study directional exit of the rhinovirus genomic 
RNA from the capsid (56). At the ultrastructural level, 
the combination of light and electron microscopy using 
a correlative light electron microscopy approach 
provides a powerful tool for the study of dynamic 
intracellular membrane trafficking events, virus entry 
and replication with high sensitivity and spatial precision 
(156-159). Such technologies may, in the future, enable 
detection of particular virus entry steps with greater 
accuracy and resolution, and give deeper insight into 
cell-cell variability of infection events. 
Reverse genetics. The advent of reverse genetics and 
molecular engineering of RNA viruses has transformed 
the field of virology by permitting study of targeted 
genetic changes in virus genomes (for examples see 
(160-162)). Pseudoviruses and virus like particles 
(VLPs) can be generated from cloned cDNAs, for 
example, allowing for reverse genetics and introduction 
of fluorescent probes (163-167). Beta-lactamase (BlaM) 
viral core chimeras, such as BlaM fused to HIV-1 viral 
protein R (vpr) can be used to detect virus uncoating 
with high sensitivity (168, 169). 
 
Systems Virology. Systems-level analyses are potent 
hypothesis generators, and analyses of systems data, 
in combination with mathematical modelling, are used 
to generate comprehensive, integrated and predictive 
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models of biological systems and virus-host interactions 
(170). Over the last decade, genome-wide RNAi 
screens have provided novel leads to study virus-host 
interactions (171). For example, such screens found 
that the interferon inducible transmembrane (IFITM) 
proteins are involved in entry of H1N1 influenza, West 
Nile, and Dengue virus (172). A recently established 
trifunctional reagent for ligand derivatization, termed 
TRICEPS, can be used to identify potential viral 
receptors on the cell surface (173). The proteomics 
informed by transcriptomics (PIT) technique allows in 
silico derivation of proteomes from transcriptomes. This 
allows generation of viral and host protein databases for 
non-model species (174). Quantitative proteomics can 
provide essential information on posttranslational 
protein modifications and interactions with other 
proteins. Among recent progress are studies with 
hepatitis C and influenza viruses (175-178), identifying 
serum response factor binding protein 1 as a potential 
uncoating factor for hepatitis C (177). VirScan is a 
versatile, high-throughput method to comprehensively 
analyze antiviral antibodies displaying proteome-wide 
coverage of peptides from all human viruses, from a 
single drop of blood (179). Evidently the synergy 
between molecular biology, viral immunology and 
systems virology reveals novel insights into virus entry 
and infection biology.  
 
 (BOX2) SFV – a model virus to study entry, 
uncoating, and immune evasion.   In 1980, Ari 
Helenius and coworkers visualized the binding of 
Semliki Forest Virus (SFV), a relatively simple 
enveloped virus to the cell surface of BHK-21 cells, 
virus internalization into coated vesicles, and 
accumulation in intracellular vacuoles. They found that 
penetration of SFV was triggered by low pH. The virus 
responded to this chemical cue by activating the fusion 
spike glycoproteins, which then mediated fusion of the 
viral envelope with the limiting membrane of the early 
endosome, followed by penetration of the viral capsid 
into the cytosol (180, 181). Within about a minute of 
reaching the cytoplasm the capsid was fully uncoated 
by the 28S large ribosomal subunit, leaving the viral 
RNA bound to the cytosolic surface of endosomes, 
where replication occurred (182, 183). Viruses that 
failed to escape from endosomes were delivered to 
lysosomes and eventually degraded (184). Infected 
cells became resistant to superinfection with SFV but 
not influenza virus. It is thought that the uncoating 
capacity of the ribosomes is inactivated during SFV 
replication precluding superinfection, and protecting 
progeny capsids from disassembly (57). Helenius and 
coworkers recently showed that immediately after 
uncoating the cellular RNA helicase Upf1 and 
nonsense-mediated mRNA decay (NMD) (185-187) 
restrict SFV replication by degrading incoming genomic 
(+)RNA (188). It is possible that alphavirus replicases 
compete with NMD to evade host restriction. 
Uncoating cues and facilitators – many viruses, 
diverse mechanisms 
Viruses make use of ubiquitous cellular processes to 
execute their uncoating program. These processes, 
ironically, often serve to maintain the cell in a healthy 
state. For example, accumulation of protein aggregates 
is a feature of cellular stress and aging in all organisms 
and associated with pathology. Protein disaggregation 
is central to the establishment of homeostasis and long 
term cell survival (189). An emerging feature of viral 
entry and uncoating is the mimicking of misfolded 
protein aggregates, so called ‘waste proteins’, in order 
to hijack cellular quality control processes that dispose 
of waste.  
 
a) Aggresome processing. Influenza virus is an 
enveloped virus. It uses histone deacetylase 6 (HDAC6) 
for uncoating. HDAC6 plays a central role in regulating 
both the concentration and autophagic clearance of 
protein aggregates (25, 190-193). After binding to sialic 
acids at the cell surface, influenza virus is taken up by 
both clathrin-mediated endocytosis (CME) and 
macropinocytosis (194-197). Virus uptake is facilitated 
by receptor tyrosine kinase signaling that is mediated 
by epidermal growth factor (EGFR) (198). The viral core 
is primed for uncoating in endosomes by H+ and K+ 
influx through the M2 ion channel (199-203), followed 
by HA-mediated viral fusion at late endosomes which 
depends on low pH, CD81 and cathepsin W (204-206). 
The capsid then exposes unanchored ubiquitin chains, 
a hallmark of misfolded protein aggregates. These 
chains are likely generated by deubiquitination of a 
poly-ubiquitinated misfolded protein that was not 
degraded by the proteasome (192, 207). They are 
exposed to the cytosol and recruit the HDAC6 zinc-
finger ubiquitin-binding domain (ZnF-UBP). HDAC6 
binds to M1 and links the capsid to dynein-, 
actomyosin- and autophagy-dependent aggresome 
processing. The generated pulling force breaks the 
capsid, promotes vRNP release and infection (25, 191, 
192) (Figure 3). Unanchored poly-ubiquitin chains are 
emerging as key factors in multiple cellular responses, 
including innate antiviral pathways (208). It will be 
interesting to find out whether the incoming ubiquitin 
chains regulate downstream signaling events during 
and after influenza uncoating. 
How does influenza virus prevent premature capsid 
uncoating during assembly? During the virus replication 
phase, HDAC6 undergoes caspase-mediated cleavage 
which inactivates both its ZnF-UBP and deacetylating 
enzyme (58, 209). This prevents premature capsid 
uncoating during virus assembly, and induces hyper-
acetylated microtubules, which in turn, promote viral 
egress and budding (58, 210).  
b) Ubiquitin proteasome system. Vaccinia virus core 
proteins are ubiquitinated during assembly and 
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packaged into virions. Viral core uncoating is driven by 
these pre-packaged ubiquitinated proteins, rather than 
by de novo ubiquitination. The core is primed for 
uncoating by the acidic pH of macropinosomes, most 
likely through a proton channel in the viral membrane 
(211). Following fusion, the core disulfide bonds are 
reduced in the cytosol. This and proteasome activity 
promote the disassembly of the lateral bodies 
(proteinaceous structures flanking the core of the 
virion), and the release of the viral phosphatase VH1 
(212). VH1 dephosphorylates signal transducer and 
activator of transcription 1 (STAT1) and protects the 
infected cells from IFN restriction (212). In addition, 
core disassembly is dependent on the viral D5 
primase/helicase, implicating that chemical energy is 
required for activating the process (145, 213-215).  
 
c) ERAD/disaggregation. Polyomavirus is a non-
enveloped virus that hijacks the ERAD machinery 
during entry. Following binding to GM1 gangliosides, 
SV40 arrives in the ER as largely unmodified particles 
(216-218). Uncoating is initiated in the ER, where the 
capsid diameter shrinks from 45 to 34nm (17, 219, 
220). The capsid is remodeled structurally and exposes 
a hydrophobic peptide which is inserted into the ER 
membrane (16, 18, 183). The hydrophobic sequence 
recruits the ERAD, and the cytosolic protein 
disaggregation machinery Hsp105, and the small 
glutamine-rich tetratricopeptide repeat-containing 
protein α (SGTA)-Hsc70 complex, which together 
translocate the penetrating capsid into the cytosol (17, 
19-23). Capsid uncoating, specifically the loss of 
interaction between the capsid protein VP1 and VP1 
pentameric capsomer, may be aided by low Ca2+ 
concentrations in the cytosol (16, 221, 222). Subviral 
particles are imported into the nucleus via NLSs 
exposed during cytosolic uncoating (223-225). 
d) Protease cleavage. Cleavage of the viral fusion 
protein is often crucial for entry, infection, and 
pathogenicity, since it enables the protein to receive 
cues from the host and insert into a host target 
membrane (24). For example, coronavirus (CoV) fusion 
(S) glycoprotein is primed by receptor binding and by 
low pH. It is proteolytically activated by endosomal 
cathepsins, and the cell surface transmembrane 
protease/serine (TMPRSS) proteases, furin, and trypsin 
(226, 227). These steps are spatiotemporally controlled. 
Binding of severe acute respiratory syndrome 
coronavirus (SARS-CoV) to its receptor angiotensin I 
converting enzyme 2 (ACE2) potentiates the S protein 
for cleavage by cathepsin L (228-231). The virus 
acquires fusogenicity in NPC1-positive endolysosomes 
where cathepsin L activity is high (232). Likewise, the 
fusion (F) protein of respiratory syncytial virus (RSV) 
undergoes cleavage by a furin-like protease twice (233, 
234). The first cleavage happens during replication in 
producer cells. After macropinocytic uptake, a second 
cleavage in F provides the cue for penetration by an 
acid-independent membrane fusion mechanism (235). 
The human papillomavirus (HPV) capsid protein L1 is 
cleaved in the extracellular space by a serine protease 
Kallikrein 8. This cleavage is crucial for further 
conformational changes of the minor capsid protein L2 
and optimal uncoating (148). 
 
e) Intracellular lysosomal receptor. Ebola and Lassa 
virus use intracellular lysosomal receptors to penetrate 
into the cytosol. As shown in Figure 4, Ebola virus 
binds to T-cell immunoglobulin and mucin domain 1 
(TIM-1) and AXL receptor tyrosine kinase for 
macropinocytic uptake by apoptotic mimicry (31, 236, 
237). After successive proteolytic priming of the 
glycoprotein (GP) by cathepsin L and cathepsin B within 
acidic vesicles, GP and the virus-bound TIM-1 interact 
with the endolysosomal receptor NPC1, leading to viral 
fusion with the limiting endosomal membrane (9, 238-
244). A monoclonal antibody against TIM-1 inhibited 
membrane fusion of several filoviruses (244). Fusion 
and endosomal escape of Ebola virus appears to 
happen from endolysosomes positive for both NPC1 
and TPC2 (two pore Ca2+ channel 2) (232, 245, 246). 
TPC1 and 2 are major endosomal Ca2+ channels 
activated by nicotinic acid adenine dinucleotide 
phosphate (NAADP), and may influence endosome 
maturation by regulating release of Ca2+ from 
endolysosomes (247, 248). 
 
Lassa virus, an arenavirus, binds O-glycans on cell 
surface dystroglycans for endocytic uptake (249). Low 
pH in late endosomes releases GP from dystroglycan 
and in turn promotes binding to N-glycosylated LAMP1. 
This receptor switching process activates membrane 
fusion and virus penetration (10, 250, 251). 
f) Endosome maturation. The endosomal network that 
receives the incoming viruses is composed of several 
different types of organelles. These are involved in 
complicated trafficking, sorting, and maturation 
processes encompassing hundreds of cellular factors. 
During endosome maturation the incoming viruses can 
gain exclusive exposure to cues that are not available 
on the plasma membrane or in the cytosol (27, 28). This 
is supported by the notion that defects in endosome or 
macropinosome maturation on the pathway from the 
plasma membrane to lysosomes inhibits the productive 
entry of many viruses (8, 30, 202, 235, 252-263). Along 
the same lines, virus entry can be inhibited by 
perturbations of microtubule-mediated vesicular traffic, 
conversion of Rab5 early to Rab7 late endosomes, or 
the formation of intralumenal vesicles (27). In addition, 
endosomal cathepsins and furin-like proteases activate 
viral fusion proteins (264). Other viruses use endosomal 
membrane proteins as intracellular receptors to execute 
particular steps of their entry program (9, 10). Viruses 
that fail to escape from the endosome are eventually 
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degraded in lysosomes. Endosomes can also trigger 
innate immunity against viruses. In plasmacytoid 
dendritic cells, toll-like receptor 7 (TLR7) recognizes the 
ssRNA genomes contained within the influenza virion 
that are taken up into the endosome (265-267).  
g) Co-opted lipid signaling. Non-enveloped viruses 
pierce or rupture the cell membrane in order to escape 
into the cytoplasm (268). As shown in Figure 5, 
adenovirus type 2 (HAdV-C2) uses membrane rupture 
twice, at the plasma membrane and endosomes, to 
gain entry into the cell. The virus first binds to its 
receptors coxsackie and adenovirus receptor (CAR) 
and integrins (269, 270). The combination of 
actomyosin-dependent drifting motion of CAR versus 
integrin-mediated confinement shears the capsid fibers 
and triggers conformational changes in the incoming 
capsid that enable externalization of the internal 
membrane lytic protein VI (11, 271). Protein VI contains 
an N-terminal amphipathic helix, and thereby creates 
small lesions in the plasma membrane, promoting 
cytosolic Ca2+ influx that in turn triggers lysosomal 
exocytosis and secretion of lysosomal acid 
sphingomyelinase (ASM) (272). ASM converts cell 
surface sphingomyelin to ceramide. This promotes virus 
uptake, which is also cholesterol- and dynamin-
dependent (259, 260). Virus containing endosomes 
have a high ceramide level which favors the binding of 
protein VI to the lipid membrane and the disruption of 
the membrane. The concerted action of mechanical and 
chemical cues (actomyosin) together with receptors 
(CAR, integrin) and facilitators (ceramide) leads to 
enhanced rupture of the limiting membrane and escape 
of the virus from non-acidic endosomes to the cytosol 
(272).  
 
Perspectives and challenges for the future 
 
Virus entry and uncoating are distinct but highly 
interlinked processes (273). They are enabled by a 
wealth of pro-viral host factors (probably hundreds for 
each virus) and antagonized by host restriction factors 
that can preclude entry or trigger inappropriate virus 
disassembly (274). Both processes have classically 
been studied independent of each other. When the two 
were connected and analyzed with dedicated 
methodology, deep mechanistic insights have been 
obtained. We expect that novel cellular cues, 
facilitators, and viral uncoating strategies will be 
discovered in the future. 
 
How will virus uncoating studies contribute to 
infectiology? An emerging challenge is to translate the 
results from cell culture experiments to primary cells 
and tissues, initially with the help of animal models and 
then human samples. Another challenge is to account 
for the fact that viruses are a cohort of particles 
infecting their target cell, tissue, organ, or organism. 
The entry pathways and uncoating factors may be 
different when cells are infected at low compared to 
high number of particles per cell (multiplicity). They may 
even depend on the nature of the producer and the 
target cells. For example, hepatitis A virus particles of 
the picornaviridae can be transmitted between cells as 
naked or lipid embedded capsids (275). The entry 
pathways for adenoviruses in epithelial cells are 
different from those in immune cells (276-278). In 
addition, the same virus can occur as diverse kinds of 
particles that use multiple entry pathways, such as 
spherical or filamentous influenza virus. All these 
features highlight the great adaptability and flexibility of 
natural infectious agents.  
 
An emerging question for today’s research in infectious 
disease is whether multiple virus infections affect one 
another. For this, methods to explore the complexity of 
the human virome in the host are being developed. For 
example, VirScan recently identified an increased rate 
of antibodies against adenovirus species C and RSV in 
HIV-positive human individuals compared with HIV-
negative individuals (179).  Are virus infections tuned by 
the bacterial microbiota? We believe that this is a 
relevant question, since mucosal surfaces of the oral, 
respiratory or intestinal tissues are major entry ports for 
viral pathogens into the human body, and these 
surfaces are colonized by microbiota, including billions 
of bacteria. We expect that in the near future the field of 
virus entry and uncoating will make increasing use of 
physiological model systems, quantitative omics, 
bioinformatics and eventually even personalized 
measurements.   
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Figure Legends 
Figure 1. Endocytic pathways involved in virus entry. The majority of viruses use endocytosis for 
entry (4, 279). The virus-carrying vesicles and vacuoles often move along microtubules towards the 
nucleus. Cellular markers for the vesicles are shown within the light-blue boxes. The pH lowers as the 
vesicles mature and approach the nucleus. Viruses (not shown) enter the endocytic pathway and 
respond to cellular cues and facilitators that serve as uncoating signals. Such cues and facilitators are 
regulated in time and space and control the stepwise uncoating program, as shown in the examples in 
Figures 2-4. Abbreviatons: EEA1, early endosomal antigen 1; ER, endoplasmic reticulum; ESCRT, 
endosomal sorting complexes required for transport; LAMP1, lysosome associated membrane protein 1; 
NPC1, Niemann-Pick Disease, Type C1; PI3P, Phosphatidylinositol 3-phosphate; SNX, syntaxin; TGN, 
trans-Golgi network. 
Figure 2. Cellular cues and processes implicated in viral uncoating. The scheme depicts cellular 
cues (receptors, enzymes, and chemicals including ions) and their cellular processes implicated in the 
stepwise uncoating of incoming virus particles. After binding to the cell surface via receptors and 
attachment factors, viruses are typically taken up into endocytic vacuoles following activation of 
signaling. They penetrate endosomes to enter the cytoplasm. Inside endosomes, viruses can be primed 
via endosome maturation, receptor binding, protease digestion, or ions. In some cases, viruses fuse 
directly at the plasma membrane to enter the cytoplasm. In the cytoplasm, viruses can be exposed to 
cellular cues and processes which culminate in the completion of uncoating and release of the viral 
genome from the capsid. The viral genome is transported to the site of replication, which may be in the 
cytosol, on cytoplasmic membranes or in the nucleus. Receptor cues (green), enzymatic cues (pink), 
chemical cues (blue), and cellular processes (white) implicated in viral uncoating are indicated. 
Facilitators are not shown. 
Abbreviatons: ERAD, ER-associated protein degradation. 
                 
 
Figure 3. Cues and facilitators of Influenza A virus entry and uncoating. After binding to sialic acids 
on the cell surface, influenza A virus induces receptor tyrosine kinase (RTK) signaling via EGFR and 
endocytosis by CME or macropinocytosis (194, 197, 198, 280-282).  CME involves Epsin1 and the virus 
particle enters Rab5-positive early endosomes (197). Macropinocytic uptake requires N-linked glycans 
on the cell surface, and also involves RTK signaling (194-196, 198). Endosome maturation and the 
influx of H+/K+ into the viral core via the M2 channel (shown by H+/K+ with white arrows) primes the virion 
for uncoating (199, 202, 203). Low pH in Rab7/LAMP1-positive late endosomes induces HA-mediated 
membrane fusion (as shown by H+ with blue arrows) (206). Unanchored ubiquitin chains are exposed to 
the cytosol, followed by recruitment of HDAC6 and the aggresome processing machinery (including 
dynein, myosin, and the cytoskeleton) to disassemble the capsid shell by mechanical force (25). CD81 
and cathepsin W also promote virus fusion (204, 205). Poly-ubiquitination of matrix protein M1 by E3 
ubiquitin ligase Itch is also implicated in uncoating (283). Following capsid disassembly, the vRNPs are 
released into the cytosol, followed by NLS-mediated import into the nucleus, viral gene transcription and 
replication (110). Receptor cues (green), enzymatic cues (pink), chemical cues (blue), facilitators 
(brown), viral protein/process (grey), and endosomal markers (light blue) are indicated. The influenza 
virion scheme was adapted from visual-science.com. 
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Abbreviatons: EGFR, epidermal growth factor receptor; HA, hemagglutinin; LAMP, LAMP, lysosome 
associated membrane protein; uUb, unanchored ubiquitin; pUb, polyubiquitin; FACIL, facilitator; VIRAL, 
viral protein/process; MARK, endosomal marker; RECEP, receptor cue; ENZYM, enzymatic cue; 
CHEM, chemical cue. 
 
Figure 4. Cues and facilitators of Ebola virus entry and uncoating. Ebola virus binds to the 
receptors TIM-1 and AXL and enters cells through classical apoptotic mimicry (31, 236, 237, 284). 
Endosome maturation, low pH, cathepsin L and cathepsin B activity prime the virus glycoprotein GP for 
fusion, an event that is also dependent on cellular factors PIKfyve and HOPS (250). Cathepsin activity is 
enhanced by low pH of endolysosomes (as shown by H+ with arrows) (285). Once the virus reaches 
NPC1/TPC2-positive endosomes TIM-1 binds NPC1, which directly or indirectly activates fusion and 
penetration (244-246). TPC2 activity is regulated by NAADP, which is a highly potent intracellular 
calcium-mobilizing agent that stimulates intracellular calcium channels to release Ca2+ from endosomes 
and lysosomes, influencing the trafficking and maturation of endosomes (248, 286). Receptor cues 
(green), enzymatic cues (pink), chemical cues (blue), facilitators (brown), viral protein/process (grey), 
and endosomal markers (light blue) are indicated. 
Abbreviatons: AXL, AXL receptor tyrosine kinase; GP, glycoprotein; HOPS, homotypic fusion and 
vacuole protein sorting; LAMP1, lysosome associated membrane protein 1; NAADP, nicotinic acid 
adenine dinucleotide phosphate; NPC1, Niemann-Pick Disease, Type C1; PIKfyve, FYVE finger-
containing phosphoinositide kinase; PS, phosphatidylserine; TIM-1, T-cell immunoglobulin and mucin 
domain 1; TPC2, two pore Ca2+ channel 2; FACIL, facilitator; VIRAL, viral protein/process; MARK, 
endosomal marker, RECEP, receptor cue; ENZYM, enzymatic cue; CHEM, chemical cue. 
 
Figure 5. Cues and facilitators of adenovirus entry and uncoating. HAdV-C2/C5 binds to CAR and 
integrins on the cell surface, and the actomyosin-dependent drifting motions of CAR trigger fiber 
shedding (2, 11, 12, 40). Virus binding to integrins induces signaling and virus uptake into endosomes in 
a dynamin-dependent manner (259, 260), Protein VI is dislocated from the inside of the virus and binds 
to the plasma membrane, forming small pores that allow influx of Ca2+ into the cytosol (272, 287). This 
danger signal induces rapid lysosomal secretion of ASM to the cell surface. ASM converts SM into CER, 
which enhances endocytic uptake of the virus. Protein VI is recruited to CER on the internal surface of 
endosomes, inducing endosomal leakage and rupture, and thereby enables escape of viral particles into 
the cytosol (260, 272, 288). Low pH is not required for virus penetration, but required to maintain 
functional secretory lysosomes (147). Receptor cues (green), enzymatic cues (pink), chemical cues 
(blue), facilitators (brown), viral protein/process (grey), and endosomal markers (light blue) are 
indicated. 
Abbreviatons: ASM, acid sphingomyelinase; CAR, coxsackie and adenovirus receptor; CER, ceramide; 
ITGN, integrin; SM, sphingomyelin; FACIL, facilitator; VIRAL, viral protein/process; RECEP, receptor 
cue; ENZYM, enzymatic cue; CHEM, chemical cue. 
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